Navigation Links
North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
Date:11/20/2008

y the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide.

The full report, including an executive summary, is available at www.ncbiotech.org/biotechnology_in_nc/battelle/battelleReport111708.pdf

A detailed accounting of the $1.2 billion in spending is located at

www.ncbiotech.org/biotechnology_in_nc/battelle/billiondollarspreadsheet.pdf

Contact: Robin Deacle, director of corporate communications, North Carolina Biotechnology Center, robin_deacle@ncbiotech.org or 919-541-9366. Visit the Biotechnology Center's Web site at www.ncbiotech.org.

Speakers include:

  • Leslie Boney III, associate vice president for economic development research, policy, and planning with the University of North Carolina;

  • Jonathan Gindes, MBA, chief financial officer and senior vice president of business development for Affinergy, a Research Triangle Park company that has received Biotechnology Center funding support;

  • John Hardin, Ph.D., acting executive director of the North Carolina Board of Science and Technology;

  • Reginald Holt, employee development coordinator at the newly opened Merck vaccine plant in Durham a
    '/>"/>

SOURCE North Carolina Biotechnology Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Frost & Sullivan Awards Baxters BioPharma Solutions Business the 2008 North American Customer Service Leadership of the Year Award
2. Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloittes 2008 Technology Fast 500
3. Northwest Secures US$1.65 Million Debt Financing
4. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
5. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
6. Circassia Acquires North American and Japanese Rights to Dopexamine
7. Endovascular Forum Inc.s President to Participate in Health 2.0 Northeast Panel
8. Northwest Secures US$1.0 Million Debt Financing
9. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
10. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
11. Natures Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TS...d that John Docherty, president and chief operatin...6th annual Investor Summit on November 10, 2009 at...r. Docherty will provide an overview of the Compan...nd Topical Interferon Alpha-2b. The slide show po...
(Date:11/6/2009)... ,, 3Q09 Corporate...a(TM) E.U. Marketing Authorization to Astellas Pha...mercial readiness activities Expanded management ...ng; and Director, Commercial Operations Appointed...t Committee chairman , Upcoming 2009 Milest...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... GenVec, Inc. (Nasdaq: ...he third quarter ended September 30, 2009. GenVec ...re) for the three months ended September 30, 2009 ...share) in the comparable quarter of 2008. For the ... loss was $14.1 million ($0.15 per share), compare...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... non-mechanical heart valve businesses expected to...over-year, MINNEAPOLIS, April 3, 2008 ATS Medica...r of state-of-the-art cardiac,surgery products and...lts,for the first quarter of 2008., (Logo: http:..., The Company currently expects revenue for the f...
...the key engineering challenges to building a clean... the fuel tank. Storing enough raw hydrogen for a ...actically high pressures for gaseous hydrogen or e...a new paper* researchers at the National Institute...esearch (NCNR) have demonstrated that a novel clas...
...ril 2, 2008 With their ability to extend,product ...as part of Big,Pharma,s strategy during lean times...rding to a new report from a major life sciences m...ipients on the market, used in all types,of pharma...healthy growth,in the past few years and is expect...
Other Biology Technology:ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million 2ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million 3More solid than solid: A potential hydrogen-storage compound 2Excipients Help Pharma Extend Product Life, Profits 2
(Date:11/9/2009)...ing Harbor, N.Y. Oncologists have had their hands...have mutations that disable a protein called p53. ...s several cancer-fighting operations within cells.... often cannot be treated. , These tumors might ...ew study from Cold Spring Harbor Laboratory (CSHL)...
(Date:11/9/2009)...versity evolutionary biologists David Queller and ...peration and low conflict between components, from..."organismality," whether that thing is an animal, ...traits scientists use to describe an organism, suc...species, may not be necessary to achieve organisma...
(Date:11/9/2009)...f academic, government and industry researchers ha...esculenta) genome. The project is an important fir...is subsistence crop and addressing some of the man... world. , Cassava is a root crop that serves as ...people each day. Although it has many properties t...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Injection May Heal Damaged Heart 52560 1Injection May Heal Damaged Heart 52560 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 1National Science Foundation Announces 2420M Research Award to South Carolina 52556 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 3More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 1More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 2
...d by researchers at the University of California, ...lements can lower concentrations of C-reactive pro...at has been shown to be a powerful predictor of he...benefit from daily doses of vitamin E, another ant...rger, eight-year clinical trial led by researchers...
...es now allow scientists to monitor changes to wate...heets and even under the ground. As the climate ch...ring its effects and predicting future impacts in ... major consequences of global warming, but it is m...rature. It involves the oceans and their interacti...
...ilable in German , , Duisburg/Leipzig. In futur...er known as acrylic glass - could be made from nat...ty acids. PMMA is manufactured by polymerising met...entists at the University of Duisburg-Essen and th...) have found an enzyme which could be used for the...
Other Biology News:Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 2Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 3Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease 4Measuring water from space 2Measuring water from space 3Acrylic glass made of sugar 2Acrylic glass made of sugar 3
ProtoArray Kinase Substrate Identification Application Kit from Invitrogen
Yeast Extract Solution from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
Biology Products: